The global value of vaccination

Vaccine

Volumn 21, Issue 7-8, 2003, Pages 596-600

  Ehreth, Jenifer ^a  

^a TULANE UNIVERSITY   (United States)

Author keywords

Burden of disease; Cost effectiveness; Vaccination

Indexed keywords

VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DIPHTHERIA; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG COST; DRUG PROGRAM; DRUG USE; ECONOMIC ASPECT; HEALTH; HEALTH CARE COST; HEPATITIS B; HUMAN; INCIDENCE; INDUSTRIALIZATION; INFLUENZA; MEASLES; MEDICAL DECISION MAKING; NEWBORN TETANUS; PERTUSSIS; PLAGUE; POLIOMYELITIS; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SMALLPOX; VACCINATION; YELLOW FEVER;

BACTERIAL INFECTIONS; COST-BENEFIT ANALYSIS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HUMANS; VACCINATION; VIRUS DISEASES; WORLD HEALTH;

EID: 0037472474     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00623-0     Document Type: Conference Paper

References (15)

1. Global Alliance For Vaccines and Immunisation (GAVI) Fact Sheet no. 169, March 2001.
2. Breiman R.F. Vaccines as tools for advancing more than public health perspectives of a former director of the national vaccine programme office. Clin. Infect. Dis. 32(2):2001;283-288.
3. Andrus JK. Vaccinology and Immunization. In: (http://www.epibiostat.ucsf.edu/igh/programmes/programmes.html) accessed June 23, 2001.
4. World Health Organization (WHO). Disease eradication, elimination goals. website (http://www.who.int/aboutwho/en/disease_er.htm) accessed June 14, 2001.
5. Centers for Disease Control and Prevention ACIP: general recommendations on immunization. MMWR 1994;43(RR-1): 1-38.
6. United Nations Foundation: Children's Health. Campaign to eradicate polio. In: (http://www.unfoundation.org/programs/children/polio.asp).
7. Henderson DA. Johns Hopkins University Annapolis Center for Science-based public policy, award acceptance remarks May 23, 2000. In: (http://www.annapoliscenter.org/henderso.html) accessed June 14, 2001.
8. Centers for Disease Control and Prevention (CDC). Immunization 2001 Annual report Centers for Disease Control and Prevention, National Immunization Programme, Atlanta, Georgia, USA.
9. Centers for Disease Control and Prevention (CDC). Global measles control and regional elimination, 1998-1999. Morb Mortal Wkly Rep 1999;48(49):1124-30.
10. Dietz V., Milstien J.B., van Loon F., Cochi S.L., Bennett J.V. Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus. J. Bull World Health Org. 74(6):1996;619-628.
11. Swartz, J, Loevinsohn B. Sustaining Effective Social Programmes; Financing Immunization in Cambodia, Lao PDR and Vietnam. Asian Development Bank, Feb 1999.
12. The World Bank. The World Bank and vaccines. In: (http://www.worldbank.org/html/extdr/hnp/healthlppi/pldevs.htm) accessed June 14, 2001.
13. White C.C., Koplan J.P., Orenstein W.A. Benefits, risks and costs of immunisation for measles mumps and rubella. Am. J. Public Health. 75:1985;739-744.
14. Washington Report: Experts Discuss Global Health Problems At Senate Appropriations Subcommittee Hearing - Copyright 1999 by United Nations Association of the United States of America - April 11, 2000. In: http://www.unausa.org/dc/info/dc041100.htm.
15. Heymann DL (WHO): Statement before the Committee on International Relations US House of Representatives. The urgency of a massive effort against infectious diseases. 29 June 2000. p. 8-36.